Internal Medicine Department
Hematology Division

George M. Rodgers, MD, PhD

Email:    george.rodgers@hsc.utah.edu

Education:

1972 – 1976    M.D., Tulane University, New Orleans, Louisiana

1970 – 1974    Ph.D. in Pharmacology, Tulane University, New Orleans, Louisiana

1966 – 1970    B.S. in Biochemistry, Louisiana State University, New Orleans, Lousiana

Training:

1979 – 1982    Fellow in Hematology/Oncology, University of California, San Francisco, San Francisco, California

1977 – 1979    Resident in Internal Medicine, Baylor College of Medicine, Houston, Texas

1976 – 1977    Intern in Medicine, Baylor College of Medicine, Houston, Texas

Research Interests:

Hemostasis regulation
Coagulation factor deficiencies
Vascular endothelial cell biology

Recent Publications

  1. Rondina MT, Markewitz B, Kling SJ, Nohavec R, Rodgers GM. (2007). The accuracy of activated partial thromboplastin times when drawn through a peripherally inserted central catheter. Am J Hematol, 82(8):738-9.
  2. Kling SJ, Jones KA, Rodgers GM. (2007). A second case of prothrombin Puerto Rico I in the United States. Am J Hematol, 82(7):661-2.
  3. Yang DT, Flanders MM, Kim H, Rodgers GM. (2006). Elevated factor XI levels are associated with an increased odds ratio for cerebrovascular events. Am J Clin Pathol, 126(3), 411-5.
  4. Flanders MM, Crist RA, Phansalkar AR, Roberts WL, Rodgers GM. (2006). Pediatric reference intervals for uncommon bleeding and thrombotic disorders. J Pediatr, 149(2), 275-7.
  5. Pendleton RC, Wheeler MM, Rodgers GM. (2006). Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated baseline aPTT due to antiphospholipic antibody syndrome. Ann Pharmacother, 40(5), 972-6.
  6. Laman CA, Silverstein SB, Rodgers GM. (2005). Parenteral iron therapy: a single institution’s experience over a 5-year period. J Natl Compr Canc Netw, 3(6), 791-5.
  7. Rodgers GM, Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF, Demitri GD, Djulbegovic B, Garst JL, Gore M, Kraut EH, Lin WC, Millenson M, Mock V, Reinke D, Rosenthal J, Sabbatini P. (2005). Cancer and treatment-related anemia. J Natl Compr Canc Netw, 3(6), 772-89.
  8. Flanders MM, Crist RA, Roberts WL, Rodgers GM. (2005). Pediatric reference intervals for seven common coagulation assays. Clin Chem, 51(9), 1738-42.
  9. Pendleton R, Wheeler M, Rodgers G. (2005). Venous thromboembolism prevention in the acutely ill medical patient: a review of the literature and focus on special patient populations. Am J Hematol, 79(3), 229-37.
  10. Stinnett JM, Pendleton R, Skordos L, Wheeler M, Rodgers GM. (2005). Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates. Am J Hematol, 78(3), 167-72.
  11. Lehman CM, Wilson LW, Rodgers GM. (2004). Analytic validation and clinical evaluation of the STA LIATEST immunoturbidimetric D-dimer assay for the diagnosis of disseminated intravascular coagulation. Am J Clin Pathol, 122(2), 178-84.
  12. Terry CM, Kling SJ, Cheang KI, Hoidal JR, Rodgers GM. (2004). Polymorphisms in the 5'-UTR of the tissue factor gene are associated with altered expression in human endothelial cells. J Thromb Haemost, 2(8), 1351-8.